|
|
Volumn 11, Issue 6, 2002, Pages 851-858
|
|
Agalsidase alfa - A preparation for enzyme replacement therapy in Anderson-Fabry disease
|
|
Author keywords
galactosidase A; Agalsidase alfa; Anderson Fabry disease; Enzyme replacement therapy; Lysosomal storage disorder
|
|
Indexed keywords
AGALSIDASE ALFA;
AGALSIDASE BETA;
ALPHA GALACTOSIDASE;
ANALGESIC AGENT;
ANTIHISTAMINIC AGENT;
CARBAMAZEPINE;
CORTICOSTEROID;
GALACTOSE;
GALACTOSIDASE;
GLOBOTRIAOSYLCERAMIDE;
GLUCOSE;
GLUCOSYLCERAMIDASE;
GLUCOSYLCERAMIDE;
GLYCOLIPID;
IMMUNOGLOBULIN A;
IMMUNOGLOBULIN E;
IMMUNOGLOBULIN M;
INULIN;
LYSOSOME ENZYME;
MORPHINE;
NARCOTIC ANALGESIC AGENT;
OLIGOSACCHARIDE;
PHENYTOIN;
PLACEBO;
POLYSORBATE 20;
SODIUM CHLORIDE;
SODIUM DIHYDROGEN PHOSPHATE;
SODIUM HYDROXIDE;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
WATER;
ISOENZYME;
RECOMBINANT PROTEIN;
ANHIDROSIS;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
AREA UNDER THE CURVE;
BRAIN DYSFUNCTION;
CATALYSIS;
CELL MUTANT;
CHILL;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CORNEA OPACITY;
DRUG BLOOD LEVEL;
DRUG COST;
DRUG DISTRIBUTION;
DRUG EFFICACY;
DRUG FORMULATION;
DRUG HALF LIFE;
DRUG SAFETY;
DRUG SCREENING;
DRUG TOLERABILITY;
ENZYME REPLACEMENT;
FABRY DISEASE;
FEMALE;
FLUSHING;
GAUCHER DISEASE;
GENE EXPRESSION;
GENETIC DISORDER;
HEART DISEASE;
HETEROZYGOTE;
HUMAN;
KIDNEY DYSFUNCTION;
LIPID DEGRADATION;
LIPID STORAGE;
MALE;
MOSAICISM;
MOUSE;
NAUSEA;
NONHUMAN;
PAIN;
PARESTHESIA;
RAT;
REVIEW;
THORAX PAIN;
ANIMAL;
CHEMISTRY;
DRUG APPROVAL;
ALPHA-GALACTOSIDASE;
ANIMAL;
DRUG APPROVAL;
FABRY DISEASE;
HUMAN;
ISOENZYMES;
RECOMBINANT PROTEINS;
ANIMALS;
HUMANS;
|
|
EID: 0036016096
PISSN: 13543784
EISSN: None
Source Type: Journal
DOI: 10.1517/13543784.11.6.851 Document Type: Review |
|
Times cited : (31)
|
|
References (32)
|
